340B Drug Pricing Program: Participation, Eligibility and Program Integrity HOSPITALS June 26 th, 2014

Similar documents
340B Pharmacy Program Compliance insight. ideas Kentucky Primary Care Association attention

Contract Pharmacy Relationships

This training will begin at 12:00pm ET. WebEx Technical Support: Or us at

Renee Gravalin, Partner

How to Survive a HRSA Audit & Take Corrective Action. William von Oehsen, Principal Powers Pyles Sutter & Verville, PC

340B Program New Developments and Increasing Scrutiny

America s Voice for Community Health Care

Table of Contents. Executive Resources, LLC 2015, v. 2

THE 340B DRUG DISCOUNT PROGRAM AND INTERPLAY WITH MEDICARE AND MEDICAID REIMBURSEMENT PRINCIPLES. Barbara Straub Williams.

Following this presentation, attendees should be able to: Identify key events in 340B landscape that occurred in 2015 and 2016.

COMPLIANCE IN THE 340B DRUG PRICING PROGRAM

MATERIAL COVERED TODAY

340B Drug Pricing: Don t Become an HRSA Statistic. Wipfli LLP 1

The 340B Drug Pricing Program: Opportunities for Community Pharmacists

340B Pharmacy Program Best Practices

2/25/2016. Today s Objectives. Disclaimer WHAT S NEW IN THE WORLD OF 340B?

Pharmaceutical Summit on Business and Compliance Issues in Managed Markets

340B Program Update & Recommendations for Monitoring Program Compliance October

10/2/2015. CPAs and ADVISORS 340B: COMPLIANCE MATTERS AND HERE S WHY MICHAEL R. EARLS, CPA DIRECTOR. experience access // 2 // experience access

Introduction. The Basics of the 340B Program. 340B Drug Discount Program Compliance, Audit & Enforcement Activity. Wesley R.

Steve Zielinski Regional Director SUNRx, LLC April 16, 2010

340B Drug Pricing Program

340B Program: Mega Guidance, Mega Change Pershing Yoakley & Associates, PC (PYA).

340B Program Contract Pharmacy Self-Audit Tool: Diversion

RE: Proposed Rule: RIN 0906-AA90, 340B Drug Pricing Program; Administrative Dispute Resolution, (Vol. 81, No. 156, August 12, 2016)

340B Drug Program Compliance: Focus on Disproportionate Hospitals

IHCP Rendering Provider Agreement and Attestation Form

The 340B Drug Pricing Program

The Federal 340B Drug Discount Program. Compliance and Lessons Learned. Jason Reddish September 24, 2014

1/16/2014. David Pointer President, SolutionsRx

Webinar Schedule. I. A Guide to the 340B Omnibus Guidance 340B Background Guide to the Guidance

Rendering Provider Agreement

340B MEGA GUIDANCE WHAT NOW? HFMA REGION 6 DECEMBER 16, 2015

A Pharmacy s Guide to 340B Contract Pharmacy Services Best Practices

Indiana Health Coverage Programs IHCP PROVIDER AGREEMENT

Ryan White & the Affordable Care Act: Frequently Asked Questions

The 340B drug discount program was created in 1992

What is the 340B Program?

Statement of Conflicts of Interest

11/5/2015 A&A PERSPECTIVE. HFMA Region 9 Conference November 15, Tracy Young, CPA, Partner Brian Bell, Director

The AIDS Drug Assistance Program Overview

Best Practices for 340B Internal Audits and Key Takeaways from the Winter 340B Coalition Conference

FPNTC FAMILY PLANNING NATIONAL TRAINING CENTER

BKD NATIONAL HEALTH CARE GROUP

340B MEGA GUIDANCE WHAT NOW? KENTUCKY HFMA WINTER INSTITUTE JANUARY 21, 2016

UNITY HEALTH Policy/Procedure Manual

E-PRESCRIBING SERVICES TERMS

CMS Unveils 12-Step Reconciliation Process For Retiree Drug Subsidy (RDS)

A. As Currently Implemented, the Recovery Purchasing Program Is Not Truly Voluntary for FSS Contractors Under Schedule 65, Part I, Section B.

From: Center for Consumer Information and Insurance Oversight (CCIIO) Title: DRAFT 2016 Letter to Issuers in the Federally-facilitated Marketplaces

Customer Access Agreement

SUPPLEMENTAL REBATE AGREEMENT Company Name

340B: WHAT ATTORNEYS NEED TO KNOW TODAY, TOMORROW AND IN THE FUTURE. March 3, 2016 ABA Emerging Issues in Healthcare Conference San Diego, CA

The 340B Program: Challenges and Opportunities

The Future of 340B. Disclosure

TX Health and Human Services Commission Proposed Rule: 340B Program Reimbursement

An Introduction to and Updated Regarding the 340B Federal Drug Discount Program

Agent Medicare Sales ATRIO Health Plans Oversight

340B Guardian Model Overview

Structuring 340B Contract Pharmacy Arrangements: Meeting Legal and Regulatory Requirements

340B Drug Discount Program: Expansion Issues, Diversion Concerns, and Implications for Price Reporting and Compliance

340B Compliance, Audits & Opportunities

340B Compliance: Overcoming Challenges with Diversion, Duplicate Discounts, and Orphan Drug Restrictions

6/11/2013. South Carolina Primary Health Care Association. Overview. 340B Essentials. Disclaimer. 340B Essentials. 340B Essentials

SECTION 8: THIRD PARTY LIABILITY (TPL) TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 1

Exclusion of Orphan Drugs for Certain Covered Entities under 340B Program

340B Program Risk: A Perspective for Pharmaceutical Manufacturers

Values Accountability Integrity Service Excellence Innovation Collaboration

Chapter 9 Medicaid and 340B

BOARD OF PHARMACY. REQUIREMENTS AND INSTRUCTIONS FOR FILING - MISCELLANEOUS PERMIT Access this form via website at:

Vendor Billing Reference Guide

Accessible, Affordable, Quality Patient Centered Medical Home

Module 3: 2015 Reinsurance Contributions Program Form Completion, Submission and Payment

USVI PROVIDER ENROLLMENT APPLICATION

ATTN: Comments on 340B Drug Pricing Program Omnibus Guidance

ESSENTIAL COMMUNITY PROVIDER PETITION FOR 2017 BENEFIT YEAR FREQUENTLY ASKED QUESTIONS

UnitedHealthcare Community Plan of Nebraska Webinar for Pharmacy Providers

AmeriHealth Website Privacy Policy and AmeriHealth Website Terms and Conditions of Access

August 11, Submitted electronically via Regulations.gov

EPS EFT New Enrollment Authorization Agreement

Patient Enrollment Guide

Formulary Services EULA

Plan Sponsor s How-To Guide

Berkshire Medical Center Billing and Collections Policy

Rx Office Hours: IMPORTANT

Texas Vendor Drug Program. Pharmacy Provider Procedure Manual Coordination of Benefits. Effective Date. February 2018

Version 7.5, August 2017 Page 1 of 11

340B Contract Pharmacy Arrangements: What Does the Future Hold?

2018 Medicare Part D Transition Policy

This document contains some basic information to assist users with creation and navigation of the MyACCESS Account and Web application.

104 Delaware Health Care Claims Database Data Access Regulation

Thank you for your interest in becoming a broker for the Counter Products offered through Sonoran National!

CENTERS FOR MEDICARE & MEDICAID SERVICES Creditable Coverage Disclosure to CMS Form Instructions and Screen Shots

Maine Chapter of the Healthcare Financial Management Association. MaineCare Provider Relations

Prevention Of Corruption

The Cecilian Bank Bill Pay Terms and Conditions. Welcome to The Cecilian Bank Online Bill Pay Service.

GlobalHealth Medicare Advantage Plans

The Allied Group Privacy Shield Policy

REINSTATEMENT And IMPLEMENTATION Of LAHIPP THIRD PARTY LIABILITY (TPL) CLAIMS PAYMENT

Generations Medicare Advantage Plans, Offered By GlobalHealth

Transcription:

340B Drug Pricing Program: Participation, Eligibility and Program Integrity HOSPITALS June 26 th, 2014 LCDR Joshua E. Hardin MBA, RN/BSN, MLT U.S. Department of Health and Human Services Health Resources and Services Administration Healthcare Systems Bureau Office of Pharmacy Affairs 1

340B Program: Overview and Benefits Provides discounts on outpatient drugs to certain safety-net covered entities Average savings of 25-50% Savings may be used to: Reduce price of pharmaceuticals for patients Expand services offered to patients Provide services to more patients Estimated 7 billion dollars in 340B drug purchases last year Manufacturers that participate in Medicaid must also participate in the 340B Program 2

Intent of the 340B Program Permits eligible safety net providers to stretch scarce Federal Resources as far as possible, reaching more eligible patients and providing more comprehensive services. H.R. Rep. No. 102-384(II), at 12 (1992) 3

340B Database Entities are not eligible for the program unless listed in the 340B database with an active ID The 340B Database is the primary source for Covered entities/manufacturers/wholesaler/opa Each clinic/site must have a specific 340B ID Wholesalers will not ship discounted drugs unless it is an exact match to the 340B database Information is updated daily Includes the Medicaid Exclusion File Online registration available for all applicants http://opanet.hrsa.gov/opa/default.aspx 4

Program Integrity Program integrity performed through 4 primary routes Enhanced initial Registration/Certification Annual Recertification Program Audits Self Disclosures and Reported Compliance allegations 5

Recertification Required by Statute (PHS Act/ACA) Ensure program integrity, compliance, transparency and accountability Ensure accuracy of covered entity information in the 340B database It is the covered entity s responsibility to ensure the accuracy of the information in the 340B database Ensure the accuracy of the Contract pharmacies listed in the database Recertification is the primary mechanism for annually capturing covered entities updated information 15 6

Current Covered Entity Recertification 2014/Current 340B Program Recertification Process all Covered Entities Covered Entity (Self Certifies Participation) OPA completes recertification 7

Changes to recertification for 2013 All entities with an active 340B ID and without a future termination date are required to recertify on the listed start date Move to local level Recertification by having the listed Authorizing Official (AO) for the parent hospital perform recertification for the parent and all child sites Verifications can be cross referenced via CMS data Determination of Whom should be listed or continue to be listed as the Authorizing Official based upon C Suite requirements 8

340B Recertification Keys Keys to successful recertification? Verify contact information is up to date in the 340B Program database prior to recertification Submit 340B Program change form to update entity information prior to recertification http://opanet.hrsa.gov/opa/crpublicsearch.aspx Monitor 340B Program webpage and your email prior to recertification Do not mistake submission of a 340B change form for performing recertification Review Recertification Users Guide (updates directly prior to recertification initiation) http://opanet.hrsa.gov/opa/userguides.aspx 9

340B Recertification Steps 1. Ensure all information in 340B Database is accurate and prepared for recertification via online change request forms or paper forms as necessary http://opanet.hrsa.gov/opa/crpublicsearch.aspx 2. All Entities currently listed in the database will be required to recertify Annually no matter the length of time of listed participation (except those sites with a pending termination date) 3. An Email with user name and Password will only be emailed to the Authorizing Official listed for the parent covered entity. Advanced notification and all general communications will be sent to the Primary Contact Also 4. Authorizing Official for the Parent will be required to recertify for Parent and all Outpatient Facilities/satellite sites/sub-grantees/sub-contractors and contract pharmacies associated with the covered entity 10

Recertification steps cont. 5. The Authorizing Official will be required to certify and update any information that is not complete. As the database has progressed throughout time, more requirements have been added and additional information may be required to be entered by Authorizing Official 6. Once Authorizing Official has completed any additional program updates they will Certify that their information is true, accurate, and that the covered entity will be in compliance with all program requirements through the Attestation language. 7. HRSA/OPA will review certifications and determine to Accept All, Accept Partial, Reject All proposed changes to the database. 8. HRSA/OPA will Recertify or Decertify the Covered Entity 9. The Authorizing Official (unless changes during the process) will receive a completion notification and will have the ability to review the Covered Entities history tab for recertification completion. 11

Covered Entity Attestation The undersigned represents and confirms that he/she is fully authorized to legally bind the covered entity and certifies that the contents of any statement made or reflected in this document are truthful and accurate. Failure to recertify may be grounds for removal from the 340B Program. The undersigned further acknowledges the 340B covered entity s responsibility to abide by the following: As an Authorized Official, I certify on behalf of the covered entity that: (1) all information listed on the 340B Program database for the covered entity is complete, accurate, and correct; 19 12

Covered Entity Attestation cont. (2) the covered entity meets all 340B Program eligibility requirements, including (if applicable) section 340B(a)(4)(L)(iii) and the Statutory Prohibition on Group Purchasing Organization Participation Policy Release 2013-1, which ensures that the covered entity hospital does not obtain covered outpatient drugs through a group purchasing organization or other group purchasing arrangement (3) the covered entity is complying with all requirements and restrictions of Section 340B of the Public Health Service Act and any accompanying regulations or guidelines including, but not limited to, the prohibition against duplicate discounts/rebates under Medicaid, and the prohibition against transferring drugs purchased under 340B to anyone other than a patient of the entity; (4) the covered entity maintains auditable records demonstrating compliance with the requirements described above; (5) the covered entity has systems/mechanisms in place to ensure ongoing compliance with the requirements described above; 13

Covered Entity Attestation cont. (6) if the covered entity uses contract pharmacy services, that the contract pharmacy arrangement is being performed in accordance with OPA requirements and guidelines including, but not limited to, that the covered entity obtains sufficient information from the contractor to ensure compliance with applicable policy and legal requirements, and the hospital has utilized an appropriate methodology to ensure compliance (e.g., through an independent audit or other mechanism); (7) the covered entity acknowledges its responsibility to contact OPA as soon as reasonably possible if there is any material change in 340B eligibility and/or material breach by the covered entity of any of the foregoing; and (8) the covered entity acknowledges that if there is a breach of the requirements described above that the covered entity may be liable to the manufacturer of the covered outpatient drug that is the subject of the violation, and, depending upon the circumstances, may be subject to the payment of interest and/or removal from the list of eligible 340B entities. 14

Recertification Lessons Learned/Helpful Hints The recertification process is a time for attestation to compliance, verification or update of covered entity data The next series of slides are reminders of common lessons learned and helpful hints for recertification above the initial steps to insuring your Authorizing Official and Primary Contact information is correct. OPA welcomes comments/recommendations on how to make the process more user friendly for all interested participants. 15

Recertification Lessons Learned/Helpful Hints Continued 1. It is highly recommended that entities print off the recertification user guide for assistance in performing recertification, (updated quarterly prior to recertification and sent as part of the user name/password email template) http://opanet.hrsa.gov/opa/manuals/opa%20database%20guide%20for%20 Public%20Users%20-%20Recertification.pdf 2. When communicating with HRSA with questions of any nature- please add your covered entities 340B ID or answers to your questions will be delayed or returned 3. It is recommended that the Authorizing Official and Primary Contact person be two separate personnel. This allows for maximum communication in the case where those entities may have one person leave their position prior to recertification, preventing an entity from losing communication channels to HRSA OPA 4. Pharmacies are not authorized to have their own unique 340B ID. 5. Work with HRSA OPA to determine best suited Authorizing Official based upon grantee structure to include subgrantees 16

Recertification Lessons Learned/Helpful Hints Continued 6. PO Boxes are only authorized for an entities billing address. PO Boxes listed via the Main Address or Shipping Address shall be removed during hospital recertification. 7. If an entity determines a site requires decertification- please be prepared to answer the following questions: A. The date that the reason for termination was effective; B. A brief description of the facts surrounding the reason for termination and how the effective date was determined; and C. The last day that 340B drugs were or will be purchased under the 340B ID 8. Entities will not be able to view changes in the general database until OPA has signed off on the entities recertification. This can be determined by viewing the dates tab (if recertified the recertification tab will hold a date of the first day of the next quarter) and history tab (will show exact date and time of HRSA OPA sign off). 17

Recertification Lessons Learned/Helpful Hints Continued 10.Entities will be given a minimum of four weeks to perform recertification, failure to perform recertification during this period will result in removal from the program. 11.Entities that wait until the last days of recertification eligibility may receive reduced technical assistance. 12.Once a covered entity selects to recertify all of its sites, the entity will lose the ability to log in and adjust its record. 13.User names and passwords from an entities last recertification are no longer valid and a new user name and password will be distributed with each recertification cycle. Once an entity has completed its portion of recertification the user name and password become a viewing only function and expire after 90 days 18

Recertification Lessons Learned/Helpful Hints Continued 14. Entities who have completed recertification and made an error or forgotten to add necessary updates should not submit additional change requests until the entities recertification has been signed off by HRSA OPA. 15. User name and Passwords are sent from 340b.recertification@hrsa.gov and HRSA@public.govdelivery.com please verify your spam filters are set to allow communication from this address 16. Once recertification has started only change requests for Authorizing Officials shall be processed. This allows HRSA OPA to get the newly listed Authorizing Official a user name and password to perform recertification in which the new Authorizing Official will be required to add their updated information. 17. Addition of a new field to collect Employer ID 19

340B Resources Prime Vendor Program (PVP) http://www.340bpvp.com No cost to participate Drug price negotiation services Discounts on over 3500 covered drugs Discounts average 15% below 340B ceiling prices Multiple wholesale distributor agreements Favorable discounts on other pharmacy related products/service 20

340B Resources Office of Pharmacy Affairs (OPA) Phone: 301-594-4353 or 1-800-628-6297 Web: http://www.hrsa.gov/opa http://www.hrsa.gov/patientsafety 340b.recertification@hrsa.gov Prime Vendor Program (PVP) Phone: 1-888-340-2787 Web: http://www.340bpvp.com ApexusAnswers@340bpvp.com (PVP is primary resource for technical assistance of the 340b program recertification) 21

Questions? 22